cells at day 1, but virtually none by day 3 ( Figure 2C ). H-rasV12-transduced cells accumulated preferentially in G1, with a cell-cycle profile indistinguishable from serum-starved control cells ( Figure 2C ; data not shown). The proportion of BrdU-positive cells in control populations was high, and declined only when cells reached confluence between days 3 and 5 ( Figure 2C ). Similarly, MEFs and REF52 cell populations transduced with H-rasV12 displayed reduced BrdU incorporation compared to vector-transduced controls (see below). Hence, explain several aspects of ras transformation and may the inability of the H-rasV12-transduced cells to proliferbe an important safeguard against neoplasia.
ate is primarily due to cell-cycle arrest rather than cell death. Cells arrested by oncogenic ras remained atResults tached to the plates and retained the same flat and enlarged morphology for at least one month (data not Oncogenic ras Provokes Cell Arrest shown). Thus, ras induces cell-cycle arrest prior to the We chose three well-characterized systems to examine onset of S phase, and this program is conserved bethe effects of oncogenic ras in normal cells: primary tween human and rodent fibroblasts. (presenescent) human diploid fibroblasts (IMR90 and WI38), primary mouse embryo fibroblasts (MEFs), and
Cell-Cycle Proteins the rat REF52 cell line. REF52 cells are immortal fibroTo characterize the nature of the cell-cycle arrest blasts but are similar to primary cells in that they discaused by H-rasV12, we examined the expression of play a high degree of growth control and require coexseveral cell-cycle regulatory proteins by immunoblotting pression of a cooperating oncogene for transformation ( Figure 3A ). Cell lysates were prepared between days 2 by ras (Franza et al., 1986 ). An activated ras allele and 4. In all three experimental systems, oncogenic ras (H-rasV12) was introduced into these cells using recomresulted in elevated p53 and p21. Furthermore, oncobinant replication-deficient retroviruses as described in genic ras also increased p16 levels. On average, p53, Experimental Procedures. The percentage of retrovirally p21, and p16 increases ranged between 10-and 20-transduced cells ranged between 60% and 100%, as fold, compared to control cells and relative to the total estimated in parallel infections using viruses expressing cellular protein content. Declines in the levels of hyperthe lacZ gene product. The retroviral vectors coexphosphorylated Rb, cyclin A, and CDK2 kinase activity pressed a puromycin phosphotransferase gene that alwere also observed in H-rasV12-transduced cells (Figlowed selection for pure populations of transduced cells ures 3A and 3B). Moderate increases in the levels of within four days. The fifth day postinfection is desigcyclin D1 were also observed in the presence of nated day 0 in all the following experiments ( Figure 1 ).
H-rasV12 (data not shown), in agreement with previous Using this protocol, we observed an approximate reports using immortal cell lines (Liu et al., 1995) . 5-to 10-fold increase in total Ras protein, compared to Decreases in the abundance of hyperphosphorylated endogenous Ras levels (data not shown).
Rb, cyclin A, and CDK2 activity are characteristic feaExpression of H-rasV12 produced morphological tures of G0/G1 arrest; for example, during quiescence changes in human IMR90 and WI38 cells. Initially, cells as a result of serum-starvation or confluence (see Dulic displayed a refractile cytoplasm with thin and long proet al., 1993) . By contrast, neither p53 nor p16 accumulate jections (data not shown). By day 2, a significant proporduring quiescence (Afshari et al., 1993; Alcorta et al., tion of H-rasV12-transduced cells became flat and en-1996) . Consequently, the G1 arrest induced by oncolarged; by day 6, virtually all cells had acquired the genic ras is different from quiescence and is specifically enlarged morphology and apparently were growth archaracterized by the simultaneous induction of the p53 rested ( Figure 2A ; data not shown for WI38). Similar and p16 tumor suppressor proteins. changes in cell morphology were observed in primary MEFs and REF52 cells (Figure 2A ; data not shown for Cellular Senescence WI38). No changes in morphology were detected in cell
The features of H-rasV12-arrested cells described populations transduced with empty viral vector (Fig- above are remarkably similar to cells that have surure 2A).
passed their proliferative capacity and become senesThe proliferative properties of such cell populations cent (Hayflick and Moorhead, 1961) . For example, sewere monitored by growth curves and by BrdU-labeling, nescent cells adopt a flat enlarged morphology and followed by flow cytometry. Cells transduced with cease proliferation at subconfluent densities despite the H-rasV12 or with empty vector were plated at low density presence of serum (reviewed by Stein and Dulic, 1995 ; and cell numbers were counted ( Figure 2B ; data not Votja and Barrett, 1995) . Also, senescent cells arrest shown for WI38 cells). Control populations grew steadily with a G1 DNA content, and express increased levels and reached confluence by day 6 (Figures 2A and 2B) .
and/or activity of p53, p21, and p16 (Noda et al., 1994 ; By contrast, H-rasV12-transduced cells stopped accu- Atadja et al., 1995; Alcorta et al., 1996; Hara et al., 1996 ; mulating well before reaching confluence (Figures 2A Reznikoff et al., 1996) . To exlore further the potential and 2B). BrdU incorporation combined with DNA-conrelationship between ras-induced arrest and senestent analysis revealed that H-rasV12-transduced popucence, we examined three additional senescence-associated markers: lack of serum-dependent induction of lations retained a small percentage of BrdU-positive c-fos (Seshadri and Campisi, 1990) , overexpression of produced no increase in the percentage of SA-␤-galthe plasminogen activator inhibitor type-1 (PAI-1) gene positive cells in IMR90 control cells ( Figure 4C and data (Goldstein et al., 1994; Mu and Higgins, 1995) , and denot shown). Thus, the cell-cycle arrest induced by oncotection of a senescence-associated ␤-galactosidase genic ras was identical to replicative senescence by (SA-␤-gal) optimally active at a pH of 6.0 (Dimri et al., every criterion tested. 1995; see also Reznikoff et al., 1996) .
To test induction of c-fos mRNA, IMR90 cells trans-E1A Bypass of Arrest duced with H-rasV12 or with empty vector were serum In rodent fibroblasts, the adenovirus E1A oncogene costarved from days 0 to 4, and then restimulated with operates with H-rasV12 to transform primary cells oncoserum. As expected, vector-transduced cells transiently genically (Ruley, 1983) . To determine whether E1A could induced c-fos 30 min after restimulation ( Figure 4A ). No circumvent ras-induced cell-cycle arrest, E1A was c-fos message was detected, however, in H-rasV12-transduced into MEF, REF52, and IMR90 cell populatransduced cells ( Figure 4A ). PAI-1 regulates cell-extrations using a vector coexpressing E1A 12S and hygrocellular matrix interactions and is translated from two mycin phosphotransferase. After selection in hygromRNAs. During senescence, both PAI-1 transcripts bemycin, E1A-expressing cells were infected with an come elevated, but the increase in expression of the H-rasV12-expressing or control virus, according to the small transcript is more pronounced (Mu and Higgins, scheme in Figure 1 . In each cell type, E1A-expressing 1995). Likewise, H-rasV12-transduced IMR90 cells disfibroblasts transduced with H-rasV12 incorporated played a significant accumulation of PAI-1 mRNA, comBrdU with efficiencies comparable to those of cells pared with vector-transduced cells (2.5-fold large trantransduced with empty vector, and proliferated rapidly script; 7.5-fold small transcript) ( Figure 4B ).
( Figures 5 and 6 ). These results indicate that E1A effiThe SA-␤-gal activity was assessed at several times ciently negates the cell-cycle arrest induced by oncopostinfection ( Figure 4C ). The percentage of SA-␤-galgenic ras, and are consistent with the observation that positive cells in H-rasV12-expressing populations was E1A cooperates with ras in transformation assays. Iminitially low, but increased at day 3 and reached 60% portantly, the levels of H-Ras proteins following introby day 6 (Figures 4C and 4D ). In contrast, about 3% duction of H-rasV12 were similar between parental and of the IMR90 cells in control cultures were SA-␤-gal E1A-expressing cells (data not shown), demonstrating positive, a value consistent with that previously dethat overexpression of H-rasV12 is not necessarily detriscribed for young IMR90 cells (Dimri et al., 1995) . Cellcycle arrest produced by serum depletion or confluence mental to cell proliferation. Both MEF and IMR90 cells expressing E1A alone displayed a normal rate of BrdU incorporation, but cell numbers accumulated slowly (compare Figures 5A and 5C with Figures 6A and 6C, respectively) . This discrepancy presumably reflects a high rate of apoptosis oc- p16 to ras-induced cell-cycle arrest, the response of (D) Photographs of the indicated IMR90 cells stained for ␤-gal (pH wild-type MEFs to oncogenic ras was compared to oth-6.0) activity at day 6. Photographs are at the same magnification.
erwise identical MEFs derived from p53-or p16-deficient mice (Jacks et al., 1994; Serrano et al., 1996) . In contrast to wild-type MEFs, p53 Ϫ/Ϫ or p16 Ϫ/Ϫ MEFs con-H-rasV12 was transduced (data not shown). These results indicate that p53 and p16 are essential for rastinued to incorporate BrdU and proliferate following introduction of H-rasV12 ( Figures 5A and 6A) . In agreeinduced arrest in MEFs, and that inactivation of either p53 or p16 alone is sufficient to circumvent arrest. ment with previous reports (Tanaka et al., 1994; Serrano et al., 1996) , both p53 Ϫ/Ϫ and p16 Ϫ/Ϫ MEFs expressing In REF52 and IMR90 fibroblasts, a different approach was needed to disrupt p53 or the p16/Rb pathway. To H-rasV12 displayed features of oncogenic transformation (e.g., refractile morphology, loss of contact inhibiinactivate p53 specifically, we transduced p53
175H
, a dominant-negative p53 mutant, in the same manner as tion), which were apparent almost immediately after was described for E1A (see Experimental Procedures).
sufficient to prevent ras-induced arrest in rodent but not in human fibroblasts. Transduction of dominant-negative p53 inactivated endogenous p53, as judged by its ability to abolish p21 expression (data not shown). To disrupt the p16/Rb
Absence of Senescence-Associated Markers pathway, we sequentially transduced cyclin D1 and in Cells Coexpressing E1A CDK4 R24C using different selectable markers (see Experiand Oncogenic ras mental Procedures). CDK4
R24C is a mutant CDK4 protein To test further the significance of the senescence markinsensitive to p16 (Wö lfel et al., 1995) , and cooperates ers induced by H-rasV12 in IMR90 cells (see above), with cyclin D1 to prevent cell-cycle arrest induced by we examined the behavior of these markers in IMR90 p16 overexpression (Bartkova et al., 1996 Lowe et al., 1994) . These results indicate arrest in REF52 cells but not in IMR90 cells. Specifically, that overexpression of PAI-1 and the presence of SA-␤-REF52/p53
175H populations transduced with H-rasV12 gal activity are not direct consequences of oncogenic showed a partial decrease in BrdU incorporation at day ras, but rather are associated with the arrested state 2, but eventually outgrew the vector-transduced REF52/ induced by ras. In this regard, our observations further p53 175H (Figures 5B and 6B) . Concordant with previously strengthen the association of these markers with cellular published results (Hicks et al., 1991) , REF52 cells coexsenescence. pressing mutant p53 and ras appeared morphologically transformed (data not shown). In contrast, IMR90/p53 175H Discussion cells transduced with H-rasV12 underwent cell-cycle arrest and displayed the large flat morphology characteris-
The effect of ras on proliferation and tumorigenesis has tic of the parental cells expressing H-rasV12 alone (Figbeen well documented in the context of immortal cell ures 5C and 6C, and data not shown). Thus, whereas p53 lines (Barbacid, 1987; Cahill et al., 1996) . However, the is essential for ras-induced arrest in rodent fibroblasts, it analysis of the effects of prolonged ras expression in appears dispensable in human fibroblasts.
primary cells has remained largely unexplored, mainly Similarly, disruption of the p16/Rb pathway by cyclin due to the limited lifespan of primary cells and to the D1/CDK4 R24C allowed escape from ras-induced arrest in low efficiencies of conventional gene transfer methods. REF52 but not in IMR90 fibroblasts. Hence, in agreement Retrovirus-mediated gene-transfer allows the introducwith the behavior of p16 Ϫ/Ϫ MEFs, REF52 cells coextion of exogenous genes with high efficiencies, such pressing cyclin D1 and p16-insensitive CDK4 R24C continthat the effects of a transduced gene can be assessed ued incorporating BrdU and proliferating upon introducin whole cell populations without significant expansion tion of H-rasV12 ( Figures 5B and 6B) . Moreover, these of the culture. We took advantage of these methods to cells became small and refractile, and showed loss of study the effects of oncogenic ras in primary cells. contact inhibiton, which are both characteristics of neoplastic transformation (data not shown). In contrast, Cell-Cycle Arrest Induced by Oncogenic ras transfer of H-rasV12 into IMR90 populations coexpressWe show that ras provokes a permanent cell-cycle arrest ing cyclin D1 and CDK4
R24C elicited the same changes in primary fibroblasts of rodent and human origin. The in cell morphology and growth as in control IMR90 cells.
arrest occurs at G1 and in association with a significant Thus, cells became large and flat, and displayed a signifincrease in the abundance of p53, p21, and p16. In this icant decrease in BrdU incorporation and growth rate regard, oncogenic activation of ras constitutes a novel ( Figures 5C and 6C) . In a parallel situation to that described for p53, disruption of the p16/Rb pathway is circumstance in which p53 is activated, and provides a oncoprotein allows escape from ras-induced arrest. The differential sensitivity between human and rodent cells to individual perturbation of p53 or the p16/Rb pathway may underlie the well-known difficulty in establishing and transforming human cell lines in culture.
Several observations indicate that ras-induced arrest is not an immediate outcome of Ras signaling, but rather a cellular response to aberrant Ras activity. The immediate effect of Ras in primary cells is mitogenic, as indicated by microinjection studies in primary human and Figure 6 . Genetic Analysis of H-rasV12-Induced Arrest: Growth Curves rodent fibroblasts (Lumpkin et al., 1986; Sullivan et al., 1986; Serrano et al., 1995) . Also, the cell-cycle arrest unprecedented. Oncogenic ras has been reported to result in proliferation arrest in REF52 fibroblasts (Franza et al., 1986; Hirakawa and Ruley, 1988) and in primary description of a stimulus that can induce p16 in association with cell-cycle arrest. It has been previously rerat Schwann cells (Ridley et al., 1988) . Oncogenic ras also induces proliferative arrest and differentiation in ported that cells lacking functional Rb overexpress p16 Hara et al., 1996) . However, the two rodent cell lines, rat pheochromocytoma PC12 cells and mouse NIH-3T3-L1 fibroblasts (Bar-Sagi and Feraabsence of functional Rb renders the cells insensitive to p16 and cells proliferate in the face of high levels of misco, 1985; Benito et al., 1991; Marshall, 1995) . However, it is important to point out that microinjection of p16 protein.
In rodent fibroblasts, disruption of either p53 or p16 Ras into Schwann and PC12 cells immediately results in proliferative arrest or differentiation, respectively (Baralone is sufficient to prevent ras-induced arrest. p53 and p16 are not thought to promote cell-cycle arrest Sagi and Feramisco, 1985; Ridley et al., 1988) . This is in contrast to primary fibroblasts, where microinjection through the same pathway; consistent with this, p16 levels increase in response to ras in p53 Ϫ/Ϫ MEFs, and of Ras initially results in proliferation (Lumpkin et al., 1986; Sullivan et al., 1986 ) and probably reflects cellp53 levels increase in p16 Ϫ/Ϫ MEFs (data not shown). Thus, ras-induced accumulation is achieved by the two type specific differences. proteins independently of one another and, at the levels achieved, neither alone is sufficient to promote arrest.
Senescence Induced by Oncogenic ras
The cell-cycle arrest induced by oncogenic ras is pheno-E1A is a viral oncoprotein known to inactivate Rb and to override p53-mediated arrest . In typically similar, and perhaps identical, to cellular senescence. Senescence was originally defined by the normal human fibroblasts, by contrast, independent disruption of either p53 or the p16/Rb pathway alone is not observation that primary fibroblasts have a limited proliferative capacity that is genetically determined (Hayflick sufficient to prevent ras-induced arrest, but the E1A and Moorhead, 1961; Rö hme, 1981; Votja and Barrett, Cell-cycle arrest in response to oncogenic ras may provide selective pressure to mutate p53 and p16 during 1995). At the end of their lifespan, cells undergo changes carcinogenesis. Consistent with this view, mutation and/ in morphology, physiology, and gene expression, and or amplification of K-ras and loss of p16 and p53 are permanently cease proliferation (Stein and Dulic, 1995) .
extremely common in human pancreatic cancers (Bos, In this state, cells remain metabolically active for long 1988; Caldas et al., 1994) . In colorectal cancer, mutation periods of time.
and/or amplification of K-ras typically precedes p53 muUnder normal culture conditions, induction of senestation (reviewed by Kinzler and Vogelstein, 1996) . In anicence depends solely on the accumulated number of mal models, p53 deficiency accelerates tumor progrescell doublings. However, a phenotype suggestive of presion in ras-transgenic mice (Kemp et al., 1993) , and mature senescence can be induced following exposure mice lacking p16 rapidly develop malignant tumors by of cell cultures to DNA-demethylating drugs (Holliday, treatment with DMBA , a carcinogen 1986; Fairweather et al., 1987) , ceramide (Venable et al., that efficiently mutates H-ras (reviewed by Barbacid, 1995) , or inhibitors of histone deacetylation (Ogryzko et 1987 (Ogryzko et ). al., 1996 . In addition, the existence of multiple potential It is possible that the effects of oncogenic ras exprespathways that can promote senescence is supported sion that we observed may not precisely reflect cellular by cell fusion studies (Votja and Barrett, 1995) . Based responses to ras mutation in vivo. Of note, we introduced on our observations, we envision that senescence ocras into whole cell populations and, consequently, Ras curs not merely as a passive consequence of a celllevels among individual cells may vary. Yet, despite this division counting mechanism, but rather as a dynamic intrinsic variability, the individual cell responses are reresponse to an aggressive mitogenic stimulus. In this markably uniform: the vast majority of cells arrest upon regard, it is possible that the normal Hayflick limit retransduction of ras, and the arrest program is conserved flects the accumulated mitogenic load that occurs durbetween fibroblasts from three species. A similar variing the lifetime of a cell culture.
ability in ras expression is also presumed in tumors, particularly in those tumors where ras proto-oncogenes Oncogene Cooperation and are amplified (Bos, 1988) . We speculate that the intensity Multistep Carcinogenesis of the ras oncogenic stimulus may affect the lag period Disruption of p53 or the p16/Rb pathway in rodent cells that precedes the induction of the cellular antiproliferais extremely efficient at abrogating ras-induced arrest.
tive response described here. In fact, oncogenic ras alone transforms primary mouse fibroblasts deficient in either p53 or p16 (Tanaka et al., Concluding Remark 1994; Serrano et al., 1996) . Hence, escape from rasWe demonstrate that oncogenic ras provokes premainduced arrest may be sufficient for transformation by ture senescence in primary rodent and human cells in oncogenic ras. Other alterations known to cooperate association with the induction of p53 and p16. We prowith ras also disrupt p53 or the p16/Rb pathway. For pose that premature induction of senescence in reexample, T-antigen inactivates p53 and Rb; cyclin D1 sponse to abnormal mitogenic signaling is a mechanism inactivates Rb by promoting its phosphorylation; the of tumor suppression. Inactivation of this antiproliferaviral oncoprotein Tax inactivates p16 (Suzuki et al., tive response allows proliferation to continue unabated 1996); the Cdc25A and -B phosphatases can activate in the presence of oncogenic stimuli. These observa-CDK2, leading to Rb inactivation; and, finally, Myc actitions could explain the apparent pressure to mutate vates the expression of Cdc25A and -B (Galaktionov genes involved in the establishment of oncogeneet al., 1996) . We propose that the cell-cycle activation induced senescence, such as p53 and p16, during tumor associated with disruption of p53 or the p16/Rb pathway progression. is necessary for transformation by oncogenic ras.
The induction of a premature senescence program by
Experimental Procedures
oncogenic ras provides an explanation for the cooperation between ras and the immortalizing mutations that
Retroviral Vectors
The following plasmids were used for generating retroviruses:
transform primary rodent cells (see Introduction). MutapBabe (Morgenstern and Land, 1990) ; pLPC (coexpresses the gene tions that facilitate immortalization may disable not only of interest from an internal CMV promoter with a puromycin resisthe senescence program associated with the accumulatance gene driven by the LTR); and pWZL (coexpresses the gene tion of cell doublings but also, and perhaps more imporof interest with a selectable marker translated from an internal ribotantly, they may impair ras-induced senescence. Simisomal entry site) (a gift of J. Morgenstern). Oncogenic ras was transduced using a pBabe-Puro-based vector expressing a human larly, most spontaneously immortalized rodent cells can H-rasV12 cDNA (pBabe-ras), although transduction of H-rasV12 using be transformed by ras alone, suggesting that raspLPC, pWZL-Hygro, or pWZL-CD8 (pWZL8ras coexpressing a CD8
induced senescence is impaired. Indeed, mutations in cell-surface marker) gave similar results (data not shown). pWZLp53 and p16 often occur spontaneously during the esHygro derivatives were used to generate retroviruses expressing tablishment of immortal cell lines (Harvey and Levine, the following proteins: an adenovirus-5 12S cDNA (pWZL12S); a 1991; Reznikoff et al., 1996; Rogan et al., 1996) . The human p53 175H mutant (pWZLp53.175); and the p16-insensitive CDK4 R24C mutant (pWZLR24C). A pWZL-Neo derivative was used to H-rasV12 allele used in this study was originally isolated express the ecotropic retroviral receptor (pWZL-Neo-EcoR), and a from tumor-derived DNA by its ability to transform NIHpLPC derivative was used to express cyclin D1 (pLPCD1).
3T3 cells, an immortal rodent cell line (Barbacid, 1987 (Jacks et al., 1994) or p16 ϩ/Ϫ mice . The head and the red organs were removed, then 1 mM EDTA). After 30 min on ice, lysates were cleared by centrifugation. Samples corresponding to 15 g of protein (BIO-RAD protein the torso was minced and dispersed in 0.1% trypsin (45 min at 37ЊC). Cells were grown for two population doublings and then assay) were separated on 10% or 15% SDS-PAGE gels and transferred to Immobilon-P membranes (Millipore). Western blot analysis frozen. The wild-type MEFs used for comparison were derived from the same crosses, and their behavior was identical regardless of was accomplished according to standard procedures using ECL detection (Amersham). The following primary antibodies were used their provenance (p53 ϩ/Ϫ cross or p16 ϩ/Ϫ cross). Human fibroblasts were used between 20 and 30 population doubling levels (PDLs);
(1:1000 unless otherwise indicated): CM5 and CM1 (Novacastra) for human and rodent p53, respectively; 1 g/ml WAF1 Ab1 (Oncogene MEFs between 3 and 5 PDLs. All cultures were maintained in DMEM (GIBCO) plus 10% fetal bovine serum (FBS; Sigma). Primary human Sciences) for human p21; an affinity-purified rabbit polyclonal antibody (Brugarolas et al., 1995) for rodent p21; DCS-50 (Novocastra) and mouse fibroblasts were subcultured 1:4 upon reaching confluence; each passage was considered two PDLs.
for human p16; M-156 (Santa Cruz) for mouse p16; a mixture of 0.5 g/ml G3-245 mouse antibody (Pharmingen) and 1:100 dilutions of the C-36 and XZ-55 hybridoma culture supernatants; and a rabbit Retroviral-Mediated Gene Transfer polyclonal antiserum against GST-human cyclin A for human and Phoenix cells (5 ϫ 10 6 ) were plated in a 10 cm dish, incubated for rodent cyclin A. Horseradish peroxidase-conjugated donkey anti-24 hr, and then transfected by calcium-phosphate precipitation with rabbit or sheep anti-mouse antibodies (Amersham) were used as 20 g of a retroviral plasmid (15 hr at 37ЊC). After 48 hr, the virussecondary antibodies. containing medium was filtered (0.45 m filter, Millipore) and supplemented with 4 g/ml polybrene (Sigma) (first supernatant). Viruses were collected for an additional 8 hr as before (second supernatant).
CDK2 Kinase Assays Target fibroblasts were plated at 8 ϫ 10 5 cells per 10 cm dish and Anti-CDK2 immunoprecipitates (Xiong et al., 1993) were washed incubated overnight. For infections, the culture medium was retwo additional times with kinase buffer (20 mM Tris-HCl [pH 8.0], placed by the appropriate first supernatant, and then the culture 10 mM MgCl2, 1 mM EDTA, 1 mM DTT), and bead suspensions ‫01ف(‬ plates were centrifuged (1 hr, 1500 rpm) and incubated at 37ЊC for l) were brought to 20 l with a solution containing 2.5 g of histone 8 hr. The infection process was repeated using the second superna-H1 (Boehringer) and 10 Ci of [␥-32 P]ATP (3000 Ci/mmol). Reaction tant. One plate of Phoenix cells produced sufficient virus for one to mixtures were incubated for 15 min at room temperature and retwo plates of target cells. Sixteen hours later, infected cell populasolved on 10% SDS-PAGE gels. H1 kinase activity was quantified tions were purified using the appropriate selection: 2 g/ml puromyusing a Fuji Phosphorimager. cin; 75 g/ml hygromycin; or 200 g/ml or 400 g/ml G418 (IMR90 and REF52 cells, respectively). Cells infected with WZL-CD8-based Northern Blots vectors were gently trypsinized and purified using magnetic beads Total RNA was isolated from subconfluent cultures (Trizol, GIBCOconjugated to anti-CD8 (Dynal). Multiple genes were introduced BRL). Ten micrograms was resolved by electrophoresis, transferred sequentially, with the appropriate drug selection between. The ecoto Hybond-Nϩ membranes, and probed according to standard protropic retrovirus receptor was introduced into human and rat fibrocedures. The 1 kb Pst1 fragment from v-fos (kindly provided by R. blasts (IMR90, WI38, and REF52) by first infecting cell populations Maestro and S. Rizzo) was used to assess c-fos expression. The with an amphotropic vector (pWZL-Neo-EcoR [a gift of D. Conklin] DNA probe for human PAI-1 was purchased from Genome Systems produced in BING cells), allowing subsequent infection with eco-(clone 268918; locus N35838). tropic viruses.
Senescence-Associated ␤-Galactosidase

Growth Curves
SA-␤-gal activity was detected as previously described (Dimri et al., Twenty-five thousand cells per well were plated into 12-well plates.
1995) with slight modifications. Cells were washed once with PBS At the indicated times, cells were washed with PBS, fixed in 10% (pH 7.2), fixed with 0.5% glutaraldehyde (PBS [pH 7.2]), and washed formalin, and rinsed with distilled water. Cells were stained with in PBS (pH 7.2) supplemented with 1 mM MgCl 2 . Cells were stained 0.1% crystal violet (Sigma) for 30 min, rinsed extensively, and dried.
in X-gal solution (1 mg/ml X-gal [Boehringer], 0.12 mM K 3 Fe[CN] 6 , Cell-associated dye was extracted with 2.0 ml 10% acetic acid. 0.12 mM K 4Fe[CN]6, 1 mM MgCl2 in PBS at pH 6.0) overnight at 37ЊC. Aliquots were diluted 1:4 with H2O, transferred to 96-well microtiter plates, and the optical density at 590 nm was determined. Values Acknowledgments were normalized to the optical density at day 0 for the appropriate cell type. Within an experiment, each point was determined in tripliWe are sincerely indebted to H. E. Ruley for his early insights about cate; each growth curve was performed at least twice. this project. We acknowledge P. Burfeind, D. Horowitz, R. Maestro, J. Morgenstern, G. P. Nolan, and S. Rizzo for help, reagents, and Cell-Cycle Analysis assistance, and we thank D. Conklin and K. Galaktionov for critical Subconfluent cultures were labeled for 4 hr with 10 M bromoreading of the manuscript. M. S. was supported by a Special Fellowdeoxyuridine (BrdU; Amersham). Cells were detached with trypsin, ship from the Leukemia Society of America. D. B. is an Investigator fixed in 50% ethanol, and treated as follows (PBS washes between of the Howard Hughes Medical Institute and is supported by grant each step): 0.1 mg/ml of RNase A for 30 min at 37ЊC; 2 M HCl, 0.5% CA68040 from the NIH. S. W. L. is supported by PHS grant CA13106 Triton X-100 for 30 min at room temperature; FITC-conjugated antifrom the NCI. BrdU (Becton Dickinson) diluted 1:5 for 1 hr at room temperature; and, finally, 5 g/ml propidium iodide, 0.1 mg/ml RNAse A, 0.1% Received December 13, 1996; revised January 29, 1997. NP-40, and 0.1% trisodium citrate. Samples were analyzed by twodimensional flow cytometry to detect both fluorescein and propidReferences ium iodide. For cytological analysis, cells were plated on coverslips, labeled with BrdU as above, and fixed in 5% acetic acid, 95% Afshari, C.A., Vojta, P.J., Annab, L.A., Futreal, P.A., Willard, T.B., ethanol (15 min at Ϫ20ЊC). Positive nuclei were visualized using the and Barrett, J.C. (1993) 
